Brainlab Takes Part in MUNICH-PINK Breast Cancer Awareness Campaign
COMPANY LIGHTS HEADQUARTERS PINK AND HOSTS EVENING EVENT
MUNICH, October 24, 2017 – Brainlab, a global leader in medical technology, took part in MUNICH-PINK last evening in support of Breast Cancer Awareness month. The company not only symbolically lit up its new headquarters in pink, but also hosted an evening event of awareness and support for affected individuals. The event, in collaboration with Estée Lauder Companies and the Munich women network, Frauen Verbinden, was attended by 250 people and featured a lecture by the breast cancer expert Prof. Dr. Marion Kiechle from the Technical University of Munich.
Stefan Vilsmeier, President and CEO of Brainlab, did not hesitate to take part in the MUNICH-PINK campaign when spontaneously approached by Frauen Verbinden, the Munich network of women in business, politics, science and media. Complete with an evening program and pink light installations, MUNICH-PINK supports the 25 year old Estée Lauder Companies global Breast Cancer Awareness campaign. In October ever year, the pink ribbon and eye-catching pink light installations are prevalent worldwide as a reminder of the importance in education and early detection for the fight against breast cancer. On Monday, prominent Munich building such as Messe München, the BMW World, the Olympia Park and the Forum roof of the Munich Airport Center, alongside the new Brainlab headquarters, were lit pink.
“We want to create as much public awareness as possible for this important yet still not sufficiently addressed topic of breast cancer,” commented Monika Dech, a founder of Frauen Verbinden and Deputy Managing Director of the Munich Convention Center. Being diagnosed with breast cancer can bring about a flurry of different thoughts and emotions. MUNICH-PINK hopes to be a sign of strength and support to those affected by the disease.
During the Frauen Verbinden evening event at Brainlab, attendees had the opportunity to hear from Prof. Dr. Marion Kiechle, Director of the Women’s Clinic of the Technical University of Munich, on the topic of “What can we do to defeat breast cancer?”. The presentation provided insights into innovative treatment methods and presented the latest research results in the fight against breast cancer. Prof Kiechle also emphasized the importance of regularly scheduled screenings and making use of medical advancements.
Modern medicine has contributed greatly to the fact that life expectancy continues to rise and that cancer is increasingly becoming a chronic disease. Over the past 25 years, Brainlab has contributed to medical advances in the treatment of cancer. Most recently, the Munich-based company has developed Elements Multiple Brain Mets SRS which generates efficient, focused-dose treatment plans for the treatment of multiple brain metastases. Past treatment approaches involved either irradiating the entire brain at once during Whole Brain Radiation Therapy (WBRT), which has been found to cause cognitive decline, or to treat each individual tumor separately, drastically increasing treatment time. Thanks to the software developed by Brainlab, it is now possible to treatment multiple brain metastases at once with quickly generated, automated plans without compromising precision and efficiency.
Brainlab develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.Brainlab develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments. Brainlab technology powers treatments in radiosurgery as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma. Founded in Munich in 1989, Brainlab has over 11,800 systems installed in over 100 countries. Learn more at brainlab.com.